Soha R. Abd El Hadi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Soha R. Abd El Hadi has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Amna Ghith
Discipline of Surgical Specialties, Adelaide Medical School, University of Adelaide, The Queen Elizabeth Hospital, Woodville South, SA 5011, Australia
1 shared publication Aya Salman
Department of Biochemistry, Faculty of Pharmacy, Egyptian Russian University, Badr City, 11829, Cairo, Egypt
1 shared publicationGhadir A. Sayed
Department of Biochemistry, Faculty of Pharmacy, Egyptian Russian University, Badr City, 11829, Cairo, Egypt
1 shared publication- Hassan Afify
Department of Pharmacology and Toxicology, Faculty of Pharmacy Egyptian Russian University Cairo Egypt
1 shared publication - Hatem A. Abdel-Aziz
Department of Applied Organic Chemistry, National Research Center, Dokki, Cairo 12622, Egypt
1 shared publication - Hesham Haffez
Biochemistry and Molecular Biology Department, Faculty of Pharmacy Capital University (formerly Helwan University) Cairo Egypt
1 shared publication
Latest Publications
- 28 March 2025
- Published by Royal Society of Chemistry (RSC) in RSC Medicinal Chemistry
- Vol. 16 (6) , 2532-2561
Unravelling the potency of the 4-oxo-2-thioxo-1,2,3,4-tetrahydropyrimidine-5-carbonitrile scaffold with S -arylamide hybrids as PIM-1 kinase inhibitors: synthesis, biological activity and in silico studies
Discovery of new PIM-1 inhibitors with the 4-oxo-2-thioxo-1,2,3,4-tetrahydropyrimidine-5-carbonitrile scaffold with S -arylamide hybrids.
- 28 March 2025
- Published by Royal Society of Chemistry (RSC) in RSC Medicinal Chemistry
- Vol. 16 (6) , 2532-2561
Unravelling the potency of the 4-oxo-2-thioxo-1,2,3,4-tetrahydropyrimidine-5-carbonitrile scaffold with S -arylamide hybrids as PIM-1 kinase inhibitors: synthesis, biological activity and in silico studies
Discovery of new PIM-1 inhibitors with the 4-oxo-2-thioxo-1,2,3,4-tetrahydropyrimidine-5-carbonitrile scaffold with S -arylamide hybrids.